- Home
- TWN vs ENGN Comparison
TWN vs ENGN Comparison
Compare TWN & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWN
- ENGN
- Stock Information
- Founded
- TWN 1986
- ENGN 1999
- Country
- TWN Hong Kong
- ENGN Canada
- Employees
- TWN N/A
- ENGN N/A
- Industry
- TWN Trusts Except Educational Religious and Charitable
- ENGN
- Sector
- TWN Finance
- ENGN
- Exchange
- TWN Nasdaq
- ENGN Nasdaq
- Market Cap
- TWN 313.8M
- ENGN 293.1M
- IPO Year
- TWN N/A
- ENGN N/A
- Fundamental
- Price
- TWN $43.08
- ENGN $7.63
- Analyst Decision
- TWN
- ENGN Strong Buy
- Analyst Count
- TWN 0
- ENGN 6
- Target Price
- TWN N/A
- ENGN $33.67
- AVG Volume (30 Days)
- TWN 20.1K
- ENGN 99.5K
- Earning Date
- TWN 01-01-0001
- ENGN 09-10-2024
- Dividend Yield
- TWN 1.10%
- ENGN N/A
- EPS Growth
- TWN N/A
- ENGN N/A
- EPS
- TWN N/A
- ENGN N/A
- Revenue
- TWN N/A
- ENGN N/A
- Revenue This Year
- TWN N/A
- ENGN N/A
- Revenue Next Year
- TWN N/A
- ENGN N/A
- P/E Ratio
- TWN N/A
- ENGN N/A
- Revenue Growth
- TWN N/A
- ENGN N/A
- 52 Week Low
- TWN $25.22
- ENGN $4.42
- 52 Week High
- TWN $41.51
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- TWN 41.14
- ENGN 42.76
- Support Level
- TWN $42.10
- ENGN $7.82
- Resistance Level
- TWN $45.96
- ENGN $8.61
- Average True Range (ATR)
- TWN 0.93
- ENGN 0.56
- MACD
- TWN -0.26
- ENGN -0.19
- Stochastic Oscillator
- TWN 25.32
- ENGN 1.18
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.